The European Molecular Biology Organisation (EMBO) is made up of over 1500 leading researchers from across Europe with a focus on promoting...

6 May 2014

Dr Caitlin Palframan, Senior Policy Manager for Breakthrough Breast Cancer, said: “Macmillan’s report highlights the alarming reality that there...

2 May 2014

Eluned Hughes, Senior Manager – Information, at Breakthrough Breast Cancer says: “We have known for some time that these risk factors play a...

2 May 2014

The Trust has signed up to the Secondary Breast Cancer Pledge, committing it to providing the best possible care to patients diagnosed with secondary...

28 April 2014

Kadcyla, also referred to as trastuzumab emtansine, or T-DM1, is a unique combination drug made up of trastuzumab (Herceptin) and a very potent...

22 April 2014

Researchers at The Institute of Cancer Research, London, proved for the first time that a group of proteins known as the anaphase-promoting complex (...

16 April 2014

The party took place at the St Pancras Renaissance Hotel with fellow Fashion Targets Breast Cancer ambassadors Antonia O’Brien, Rosie Fortescue,...

11 April 2014

New research led by scientists at the Wellcome Trust Sanger Institute in Cambridge, and part-funded by Breakthrough Breast Cancer, has provided...

11 April 2014

Eluned Hughes, Senior Manager - Information at Breakthrough Breast Cancer, said: “This is an important finding because it's difficult to unpick...

10 April 2014